Back to trial details

Intake questionnaire

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Applying to Rush University Medical Center · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you between 18 and 80 years old?
2. Have you been diagnosed with Crohn Disease?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Chicago for study visits?